BORYUNG PHARMACEUTICAL CO LTD has a total of 14 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Taiwan, Australia and Singapore. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SQUIRES MERYL, OYSTER POINT PHARMA INC and TARCIC NORA.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Nam Kyung Wan | 4 |
#2 | Son Mi-Kwon | 3 |
#3 | Kim Sang Yeop | 3 |
#4 | Kim Je Hak | 3 |
#5 | Kim Nam-Hoon | 3 |
#6 | Lee Joo Han | 3 |
#7 | Kim Ji Han | 3 |
#8 | Choi Yeon-Seo | 3 |
#9 | Hwang Yong-Youn | 2 |
#10 | Kim Myung-Sic | 2 |
Publication | Filing date | Title |
---|---|---|
TW201938168A | Pharmaceutical composition for preventing or treating cancer comprising PI3 kinase inhibitor and immune checkpoint inhibitor | |
AU2014230182A1 | Pharmaceutical combination drug |